117 related articles for article (PubMed ID: 6683629)
21. Phase II evaluation of vindesine in mycosis fungoides, extraosseous plasmacytoma and other hematologic malignancies.
Ferrazzi E; Pappagallo GL; Segati R; Vinante O; Galligioni E; Zagonel V; Salvagno L; Fiorentino MV
Tumori; 1982 Aug; 68(4):321-4. PubMed ID: 7147357
[TBL] [Abstract][Full Text] [Related]
22. Phase II trial of vindesine in patients with squamous cell cancer of the head and neck.
Sledge GW; Clark GM; Griffin C; Mattox DE; Von Hoff DD
Am J Clin Oncol; 1984 Jun; 7(3):209-11. PubMed ID: 6731343
[TBL] [Abstract][Full Text] [Related]
23. Vindesine in the treatment of metastatic breast cancer.
Hansen PV; Brincker H
Eur J Cancer Clin Oncol; 1984 Oct; 20(10):1221-5. PubMed ID: 6541581
[TBL] [Abstract][Full Text] [Related]
24. Phase I evaluation of vindesine in children: a Southwest Oncology Group pilot study.
Komp D; Vats T; Shepherd DA; Vietti T; Hoogstraten B; Haas CD
Med Pediatr Oncol; 1980; 8(3):243-50. PubMed ID: 7193278
[TBL] [Abstract][Full Text] [Related]
25. Broad phase II study of vindesine.
Valdivieso M; Bedikian AY; Bodey GP; Freireich EJ
Cancer Treat Rep; 1981; 65(9-10):877-9. PubMed ID: 7273021
[TBL] [Abstract][Full Text] [Related]
26. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F
Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
[TBL] [Abstract][Full Text] [Related]
27. Phase II evaluation of vindesine for patients with advanced colorectal carcinoma.
Saiers JH; Slavik M; McKinney DR
Cancer Treat Rep; 1982 Mar; 66(3):583-4. PubMed ID: 7060047
[No Abstract] [Full Text] [Related]
28. Vindesine in the treatment of refractory hematologic malignancies: a phase II study.
Mandelli F; Amadori S; Giona F; Antonietta M; Spiriti A; Pastore S; Meloni G; Paolucci G
Leuk Res; 1982; 6(5):649-52. PubMed ID: 7154707
[TBL] [Abstract][Full Text] [Related]
29. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.
Le Chevalier T; Brisgand D; Douillard JY; Pujol JL; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S
J Clin Oncol; 1994 Feb; 12(2):360-7. PubMed ID: 8113844
[TBL] [Abstract][Full Text] [Related]
30. Vindesine: an effective agent in the treatment of non-small cell lung cancer.
Furnas BE; Williams SD; Einhorn LH; Cobleigh MA
Cancer Treat Rep; 1982 Sep; 66(9):1709-11. PubMed ID: 7116347
[TBL] [Abstract][Full Text] [Related]
31. Initial clinical studies of vindesine.
Valdivieso M; Richman S; Burgess AM; Bodey GP; Freireich EJ
Cancer Treat Rep; 1981; 65(9-10):873-5. PubMed ID: 6268296
[TBL] [Abstract][Full Text] [Related]
32. Vindesine. A review of phase-II trials.
Gralla RJ; Tan CT; Young CW
Cancer Chemother Pharmacol; 1979; 2(4):271-4. PubMed ID: 455587
[TBL] [Abstract][Full Text] [Related]
33. Vindesine. A phase II trial in advanced breast cancer patients.
Robins HI; Tormey DC; Skelley MJ; Falkson G; Crowley JJ; Ramirez G; Falkson H
Cancer Clin Trials; 1981; 4(4):371-5. PubMed ID: 7318120
[TBL] [Abstract][Full Text] [Related]
34. Vindesine in the treatment of malignant mesothelioma: a phase II study.
Kelsen D; Gralla R; Cheng E; Martini N
Cancer Treat Rep; 1983 Sep; 67(9):821-2. PubMed ID: 6883358
[TBL] [Abstract][Full Text] [Related]
35. Vindesine in bronchogenic carcinoma: a phase II trial.
Vogelzang NJ; Peterson BA; Kennedy BJ; Vosika GJ; Conroy JA
Am J Clin Oncol; 1982 Feb; 5(1):41-4. PubMed ID: 6282107
[TBL] [Abstract][Full Text] [Related]
36. [Phase II study of vindesine in hematological malignancies].
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2509-15. PubMed ID: 6580841
[TBL] [Abstract][Full Text] [Related]
37. Phase I and II studies of vindesine.
Valdivieso M
Cancer Treat Rev; 1980 Sep; 7 Suppl 1():31-7. PubMed ID: 7438119
[No Abstract] [Full Text] [Related]
38. EORTC phase II trial of vindesine in advanced melanoma.
Rümke P; Everall JD; Mulder JH; Rozencweig M; Czarnetzki B; Thomas D
Eur J Cancer Clin Oncol; 1983 Aug; 19(8):1173-4. PubMed ID: 6684562
[No Abstract] [Full Text] [Related]
39. Sequential phase II studies of chemotherapy for colorectal cancer with 5-fluorouracil and vindesine with or without methyl-1,3 cis(2 chloroethyl)-1-nitrosourea.
Stroehlein JR; Bedikian AY; Karlin DA; Valdivieso M; Bennetts RW; Bodey GP
Am J Clin Oncol; 1982 Aug; 5(4):421-7. PubMed ID: 7113964
[TBL] [Abstract][Full Text] [Related]
40. Neurological toxicity of vindesine used in combination chemotherapy of 51 human solid tumors.
Focan C; Olivier R; Le Hung S; Bays R; Claessens JJ; Debruyne H
Cancer Chemother Pharmacol; 1981; 6(2):175-81. PubMed ID: 7307235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]